01478nam 2200397 a 450 991069370480332120040203085739.0(CKB)4970000000046694(OCoLC)54344431ocm54344431(OCoLC)994970000000046694(EXLCZ)99497000000004669420040203d2003 ua 0engurmn||||||txtrdacontentcrdamediacrrdacarrierPrescription drugs[electronic resource] state and federal oversight of drug compounding by pharmacies /statement of Janet Heinrich, Director, Health Care, Public Health Issues[Washington, D.C.] :U.S. General Accounting Office,[2003]Testimony ;GAO-04-195 TTitle from title screen (viewed on Jan. 31, 2004)."For release ... October 23, 2003."Paper version available from: General Accounting Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548.Includes bibliographical references.Prescription DrugsDrugsDosage formsUnited StatesEvaluationDrugsDosage formsEvaluation.Heinrich Janet1380701United States.General Accounting Office.GPOGPODOCUMENT9910693704803321Prescription drugs3428110UNINA